BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 393525)

  • 1. Characterization of furosemide-induced activation of the renal prostaglandin system.
    Ciabattoni G; Pugliese F; Cinotti GA; Stirati G; Ronci R; Castrucci G; Pierucci A; Patrono C
    Eur J Pharmacol; 1979 Dec; 60(2-3):181-7. PubMed ID: 393525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of furosemide, captopril and indometacin on the renin-angiotensin system and the renal prostaglandins in anesthetized neonatal piglets.
    Joppich R; Weyer P; Eife R
    Arzneimittelforschung; 1995 Jul; 45(7):822-5. PubMed ID: 8573231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of indomethacin on furosemide induced renal prostaglandin synthesis and action in man.
    Kim RB; McCauley FA; Wilson TW
    Clin Invest Med; 1986; 9(3):192-7. PubMed ID: 3530574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Responses to furosemide in normotensive and hypertensive subjects.
    Wilson TW
    Clin Pharmacol Ther; 1983 Nov; 34(5):590-5. PubMed ID: 6688772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of furosemide-induced natriuresis by direct stimulation of renal prostaglandin E2.
    Katayama S; Attallah AA; Stahl RA; Bloch DL; Lee JB
    Am J Physiol; 1984 Oct; 247(4 Pt 2):F555-61. PubMed ID: 6594069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing the "redirection hypothesis" of prostaglandin metabolism in the kidney.
    Datar S; McCauley FA; Wilson TW
    Prostaglandins; 1987 Feb; 33(2):275-85. PubMed ID: 3296006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulindac is not renal sparing in man.
    Roberts DG; Gerber JG; Barnes JS; Zerbe GO; Nies AS
    Clin Pharmacol Ther; 1985 Sep; 38(3):258-65. PubMed ID: 4028619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low plasma renin activity in diabetes. Relation to urine prostaglandin excretion.
    Wilson TW; Tan LK
    Diabetes; 1985 Feb; 34(2):145-50. PubMed ID: 3881302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction by indomethacin of furosemide effects in the rabbit.
    Oliw E; Kövér G; Larsson C; Anggård E
    Eur J Pharmacol; 1976 Jul; 38(1):95-100. PubMed ID: 954837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of experimental salt depletion on urinary prostanoid excretions in normal women.
    Agnoli GC; Borgatti R; Cacciari M; Lenzi P; Marinelli M; Stipo L
    Prostaglandins Leukot Essent Fatty Acids; 1998 Mar; 58(3):237-42. PubMed ID: 9610848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal study of renal prostaglandin excretion in cirrhotic rats: relationship with the renin-aldosterone system.
    Solà J; Camps J; Arroyo V; Guarner F; Gaya J; Rivera F; Rodes J
    Clin Sci (Lond); 1988 Sep; 75(3):263-9. PubMed ID: 3046823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Volume-induced natriuresis in healthy women: renal metabolism of prostacyclin and thromboxane, and physiological role of prostanoids.
    Agnoli GC; Borgatti R; Cacciari M; Lenzi P; Marinelli M; Stipo L
    Prostaglandins Leukot Essent Fatty Acids; 2001 Feb; 64(2):95-103. PubMed ID: 11237476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of specific COX-2-inhibition on renin release and renal and systemic prostanoid synthesis in healthy volunteers.
    Stichtenoth DO; Marhauer V; Tsikas D; Gutzki FM; Frölich JC
    Kidney Int; 2005 Nov; 68(5):2197-207. PubMed ID: 16221219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute effect of furosemide on renal kallikrein and prostaglandin systems in mild to moderate essential hypertension.
    Franchi F; Lo Sapio P; Strazzulla G; Fabbri G; Scardi A; Pinzani M; Laffi G; Mannelli M
    Int J Clin Pharmacol Ther Toxicol; 1987 Jan; 25(1):44-9. PubMed ID: 3549580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of renal kallikrein and prostaglandin in the control of renin release.
    Suzuki S; Kobayashi M; Hashiba K
    Jpn Heart J; 1986 Jan; 27(1):83-93. PubMed ID: 2425102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase of free arachidonic acid by furosemide in man as the cause of prostaglandin and renin release.
    Weber PC; Scherer B; Larsson C
    Eur J Pharmacol; 1977 Feb; 41(3):329-32. PubMed ID: 837974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin excretion after furosemide in normal and low-renin essential hypertension.
    Scherer B; Witzgall H; Weber PC
    Klin Wochenschr; 1984 Aug; 62(16):777-82. PubMed ID: 6384651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of furosemide on renal function in the stenotic and contralateral kidneys of patients with renovascular hypertension.
    Ruilope L; Garcia-Robles R; Sancho-Rof J; Paya C; Rodicio JL; Strong CG; Knox FG; Romero JC
    Hypertension; 1983; 5(6 Pt 3):V43-7. PubMed ID: 6360882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of angiotensin II in renal prostaglandin E2 production after furosemide administration.
    Fujimura A; Ebihara A
    Hypertension; 1988 May; 11(5):491-4. PubMed ID: 3284821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of sodium intake on rabbit renal prostaglandin E2 and thromboxane A2: dissociation from the renin-angiotensin system.
    Attallah AA
    Clin Sci (Lond); 1987 May; 72(5):605-9. PubMed ID: 3555966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.